A Study to Evaluate Safety and Immunogenicity of One or Two Booster Vaccinations With H5N6 Influenza Vaccine in Adults Primed With H5N1 Influenza Vaccine or Unprimed

Clinical trial NCT05422326 · COMPLETED

Trial details

NCT number: NCT05422326
Sponsor: Seqirus
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Influenza, Human Influenza in Birds Respiratory Tract Infections Infections Orthomyxoviridae Infections RNA Virus Infections Virus Diseases Respiratory Tract Diseases

Start date: 2022-07-18
Primary completion: 2022-10-24
Enrollment: 260

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.